<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/96EFA8D6-9087-45CB-B5F1-FFAFE8D3BE64"><gtr:id>96EFA8D6-9087-45CB-B5F1-FFAFE8D3BE64</gtr:id><gtr:name>Sangamo Biosciences, Inc</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/743B0403-114A-4062-A04B-26B6E57DE502"><gtr:id>743B0403-114A-4062-A04B-26B6E57DE502</gtr:id><gtr:name>Columbia University</gtr:name><gtr:address><gtr:line1>Columbia University</gtr:line1><gtr:line2>2960 Broadway</gtr:line2><gtr:line4>New York</gtr:line4><gtr:line5>NY 10027-6902</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0E33620F-A4FE-4DC2-914B-EE7F9B5EC0C2"><gtr:id>0E33620F-A4FE-4DC2-914B-EE7F9B5EC0C2</gtr:id><gtr:name>University Hospital Bonn</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A97A8EC9-C79E-4701-BC21-6F259E0C8AE9"><gtr:id>A97A8EC9-C79E-4701-BC21-6F259E0C8AE9</gtr:id><gtr:name>Oslo University Hospital</gtr:name><gtr:address><gtr:line1>Ullevaal</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F53AAC5E-F39C-4570-AD7E-0B995E0F8FD2"><gtr:id>F53AAC5E-F39C-4570-AD7E-0B995E0F8FD2</gtr:id><gtr:name>University of Miami</gtr:name><gtr:address><gtr:line1>1204 Dickinson Drive</gtr:line1><gtr:line2>Rhodes House</gtr:line2><gtr:line3>Building 37-A</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9427D3A3-9888-4F5E-91C4-0909FE14005C"><gtr:id>9427D3A3-9888-4F5E-91C4-0909FE14005C</gtr:id><gtr:name>South Australian Clinical Genetics Service</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C6D0044A-2CD2-4167-B90B-922AF53E361F"><gtr:id>C6D0044A-2CD2-4167-B90B-922AF53E361F</gtr:id><gtr:name>University of Kent</gtr:name><gtr:address><gtr:line1>The Registry</gtr:line1><gtr:line4>Canterbury</gtr:line4><gtr:line5>Kent</gtr:line5><gtr:postCode>CT2 7NZ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9EED95BB-25DC-4032-8E45-C3EA7277E78A"><gtr:id>9EED95BB-25DC-4032-8E45-C3EA7277E78A</gtr:id><gtr:name>University of Milan</gtr:name><gtr:address><gtr:line1>Via Festa del Perdono 7</gtr:line1><gtr:postCode>20122</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/618C6FA2-F2EB-4646-BB45-7927F09D69C4"><gtr:id>618C6FA2-F2EB-4646-BB45-7927F09D69C4</gtr:id><gtr:name>Helmholtz Zentrum M?nchen</gtr:name><gtr:address><gtr:line1>German Center f. Environmental Research</gtr:line1><gtr:line2>Ingolst?dter Landstr. 1</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/76119A17-D4F8-4258-80F0-C8B307FFFA52"><gtr:id>76119A17-D4F8-4258-80F0-C8B307FFFA52</gtr:id><gtr:name>Radboud University Nijmegen</gtr:name><gtr:address><gtr:line1>Radboud University Nijmegen</gtr:line1><gtr:line2>PO Box 9102</gtr:line2><gtr:line4>Nijmegen</gtr:line4><gtr:postCode>6500 HC</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D739677A-6514-46E5-821F-22EEA573D62A"><gtr:id>D739677A-6514-46E5-821F-22EEA573D62A</gtr:id><gtr:name>University of Ghent</gtr:name><gtr:address><gtr:line1>Rectorate Building</gtr:line1><gtr:line2>Sint-Pietersnieuwstraat 25</gtr:line2><gtr:line3>Krijgslaan</gtr:line3><gtr:postCode>B-9000</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AFCF678A-5FC2-4D86-B376-12C1457C0F14"><gtr:id>AFCF678A-5FC2-4D86-B376-12C1457C0F14</gtr:id><gtr:name>Columbia University Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5053B8F1-C125-4EA2-9951-1CEC5AE08D3B"><gtr:id>5053B8F1-C125-4EA2-9951-1CEC5AE08D3B</gtr:id><gtr:name>Carlo Besta Neurological Institute</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/96EFA8D6-9087-45CB-B5F1-FFAFE8D3BE64"><gtr:id>96EFA8D6-9087-45CB-B5F1-FFAFE8D3BE64</gtr:id><gtr:name>Sangamo Biosciences, Inc</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/743B0403-114A-4062-A04B-26B6E57DE502"><gtr:id>743B0403-114A-4062-A04B-26B6E57DE502</gtr:id><gtr:name>Columbia University</gtr:name><gtr:address><gtr:line1>Columbia University</gtr:line1><gtr:line2>2960 Broadway</gtr:line2><gtr:line4>New York</gtr:line4><gtr:line5>NY 10027-6902</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0E33620F-A4FE-4DC2-914B-EE7F9B5EC0C2"><gtr:id>0E33620F-A4FE-4DC2-914B-EE7F9B5EC0C2</gtr:id><gtr:name>University Hospital Bonn</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A97A8EC9-C79E-4701-BC21-6F259E0C8AE9"><gtr:id>A97A8EC9-C79E-4701-BC21-6F259E0C8AE9</gtr:id><gtr:name>Oslo University Hospital</gtr:name><gtr:address><gtr:line1>Ullevaal</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F53AAC5E-F39C-4570-AD7E-0B995E0F8FD2"><gtr:id>F53AAC5E-F39C-4570-AD7E-0B995E0F8FD2</gtr:id><gtr:name>University of Miami</gtr:name><gtr:address><gtr:line1>1204 Dickinson Drive</gtr:line1><gtr:line2>Rhodes House</gtr:line2><gtr:line3>Building 37-A</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9427D3A3-9888-4F5E-91C4-0909FE14005C"><gtr:id>9427D3A3-9888-4F5E-91C4-0909FE14005C</gtr:id><gtr:name>South Australian Clinical Genetics Service</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C6D0044A-2CD2-4167-B90B-922AF53E361F"><gtr:id>C6D0044A-2CD2-4167-B90B-922AF53E361F</gtr:id><gtr:name>University of Kent</gtr:name><gtr:address><gtr:line1>The Registry</gtr:line1><gtr:line4>Canterbury</gtr:line4><gtr:line5>Kent</gtr:line5><gtr:postCode>CT2 7NZ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9EED95BB-25DC-4032-8E45-C3EA7277E78A"><gtr:id>9EED95BB-25DC-4032-8E45-C3EA7277E78A</gtr:id><gtr:name>University of Milan</gtr:name><gtr:address><gtr:line1>Via Festa del Perdono 7</gtr:line1><gtr:postCode>20122</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/618C6FA2-F2EB-4646-BB45-7927F09D69C4"><gtr:id>618C6FA2-F2EB-4646-BB45-7927F09D69C4</gtr:id><gtr:name>Helmholtz Zentrum M?nchen</gtr:name><gtr:address><gtr:line1>German Center f. Environmental Research</gtr:line1><gtr:line2>Ingolst?dter Landstr. 1</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/76119A17-D4F8-4258-80F0-C8B307FFFA52"><gtr:id>76119A17-D4F8-4258-80F0-C8B307FFFA52</gtr:id><gtr:name>Radboud University Nijmegen</gtr:name><gtr:address><gtr:line1>Radboud University Nijmegen</gtr:line1><gtr:line2>PO Box 9102</gtr:line2><gtr:line4>Nijmegen</gtr:line4><gtr:postCode>6500 HC</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D739677A-6514-46E5-821F-22EEA573D62A"><gtr:id>D739677A-6514-46E5-821F-22EEA573D62A</gtr:id><gtr:name>University of Ghent</gtr:name><gtr:address><gtr:line1>Rectorate Building</gtr:line1><gtr:line2>Sint-Pietersnieuwstraat 25</gtr:line2><gtr:line3>Krijgslaan</gtr:line3><gtr:postCode>B-9000</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AFCF678A-5FC2-4D86-B376-12C1457C0F14"><gtr:id>AFCF678A-5FC2-4D86-B376-12C1457C0F14</gtr:id><gtr:name>Columbia University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5053B8F1-C125-4EA2-9951-1CEC5AE08D3B"><gtr:id>5053B8F1-C125-4EA2-9951-1CEC5AE08D3B</gtr:id><gtr:name>Carlo Besta Neurological Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9935A275-D6AA-4613-A2C0-C7FB30F97832"><gtr:id>9935A275-D6AA-4613-A2C0-C7FB30F97832</gtr:id><gtr:firstName>Michal</gtr:firstName><gtr:surname>Minczuk</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105697135"><gtr:id>C7C539FA-8B33-4E65-8EC2-7007D2A6F0E5</gtr:id><gtr:title>Mitochondrial Genetics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105697135</gtr:grantReference><gtr:abstractText>In eukaryotic organisms almost all genetic information is encoded in DNA present in the nucleus of the cell, but a small DNA molecule inhabits mitochondria, cellular structures that provide energy from food for the cells to use. Mitochondrial DNA contains genes that are vital for the physiological functioning of the cell. Defects that directly or indirectly affect mitochondrial genes cause human diseases. We are still do not know how mitochondrial genes work exactly. One of the ways to investigate the role of a gene, or to discover its biological function, it to change or disrupt DNA, and then to look for the effect on cultured cells, or on the whole organism. These methods of genetic modification are often powerful ways of studying disease genes encoded in the nucleus, but they cannot be applied to mammalian mitochondrial DNA. Therefore, our research goals are to identify new genes regulating mitochondria, define how these mitochondrial genes operate and to provide the technology to allow mammalian mitochondrial DNA to be modified genetically. It could be an invaluable way of understanding mitochondrial diseases and for advancing the quest for therapies.</gtr:abstractText><gtr:technicalSummary>Human mitochondria have their own genome (mtDNA) that is two hundred thousand times smaller that the nuclear genome (nDNA) and encodes only thirteen essential subunits of the oxidative phosphorylation (OXPHOS) machinery. Given the relatively small size of the mitochondrial genome our detailed understanding of the molecular mechanism that govern mitochondrial gene maintenance and expression is still surprisingly sketchy. Defects of mtDNA and nDNA are well-recognised cause of genetic disorders that have diverse clinical manifestations ranging from progressive muscle weakness to fatal infantile disease. Much of our understanding of mitochondrial molecular genetics has come from studying rare mitochondrial disorders. Currently there are no effective treatments for these diseases and there are very few animal models for them. The slow progress in gathering more data on how mitochondrial genome is regulated is, in large part, owing to our current inability to edit mtDNA. Genome engineering techniques, analogous to the ones routinely used to modify the nuclear DNA, are not in hand, so we are unable to interrogate the role of cis-acting elements for RNA expression as well as transcription or replication. Furthermore, we are still unable to introduce pathogenic mtDNA mutations at will so their effect could be studied in animal models. 

In particular, the programme focuses on:

(i) Studying the basic mechanisms of mitochondrial genome regulation with the main focus on
the novel proteins responsible for nuclolytic processing of precursor mitochondrial RNA, polyadenylation of mitochondrial messenger RNA, post-transcriptional nucleotide modification of mitochondrial RNA and mitoribosome biogenesis.

(ii) The analysis of the key aspects of mitochondrial genome regulation in samples derived from patients affected with mitochondrial disease. This analysis is a source of valuable insights into the pathomechanisms of human disease, and also into basic mitochondrial molecular genetics. Importantly. They provide patients with a molecular diagnosis for prevention (prenatal genetic diagnosis) and counselling. 

(iii) Developing new approaches for the genetic modification of mitochondria of living cells. 
The key long-term aim is to establish routine methods of genetic modification of mammalian mitochondria. Enzymatic methods are being developed to modify the mitochondrial genome e.g. engineered zinc finger nucleases are delivered to mitochondria in order to deplete cells selectively of specific mtDNA variants.</gtr:technicalSummary><gtr:fund><gtr:end>2017-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>4022854</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ghent</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Mitochondrial RNA metabolism and human disease</gtr:description><gtr:id>1FF9DCEB-FB43-4472-9291-D323572B8A81</gtr:id><gtr:impact>Several papers e.g: 

Van Haute L, Dietmann S, Kremer L, Hussain S, Pearce SF, Powell CA, Rorbach J, Lantaff R, Blanco S, Sauer S, Kotzaeridou U, Hoffmann GF, Memari Y, Kolb-Kokocinski A, Durbin R, Mayr JA, Frye M, Prokisch H, Minczuk M.Deficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3. Nat Commun. 2016 Jun 30;7:12039. doi: 10.1038/ncomms12039.

Haack, T.B.*, Kopajtich, R.*, Freisinger, P.*, Wieland, T., Rorbach, J, Nicholls, T.J., Enrico Baruffini, E., Walther, A., Danhauser, K., Zimmermann, F.A., Husain, R.A., Schum, J., Mundy, H., Ferrero, I., Strom, T.M., Meitinger, T., Taylor, R.W., Minczuk, M**., Mayr, J.A., Prokisch, H.** (2013) ELAC2 Mutations Cause a Mitochondrial RNA Processing Defect Associated with Hypertrophic Cardiomyopathy. Am J Hum Genet 93, 211-223

Kopajtich, R.,* Nicholls, T.J.,* Rorbach, J.,* Freisinger, P., Mandel, H., Vanlander, A., Ghezzi, D., Carrozzo, R., Taylor, R.W., Marquard, K., Murayama, K., Wieland, T., Schwarzmayr, T., Mayr, J.A., Pearce, S. F., Powell, C. Saada, A., Ohtake, A., Invernizzi, F., Lamantea, E., Sommerville, E. W., Pyle, A., Chinnery, P. F., Crushell, E., Okazaki, Y., Kohda, M., Kishita, Y., Tokuzawa, Y., Smet, J., R&amp;eacute;gal, L., Lorber, A., Khoury, A., Zeviani, M., Strom, T. M., Meitinger, T., Bertini, E. S., Van Coster, R., Klopstock, T., Haack, T. B., Minczuk, M.,** Prokisch, H.** (-) Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis and encephalopathy Am J Hum Genet 95, 708-20

Vanlander, A.V., Menten, B., Smet, J., De Meirleir, L., Sante, T., De Paepe, B., Seneca, S., Pearce, S.F., Powell, C.A., Vergult, S., Michotte, A., De Latter, E., Vantomme, L., Minczuk, M. and Van Coster, R. (-) Two siblings with homozygous pathogenic splice site mutation in mitochondrial asparaginyl-tRNA synthetase (NARS2) Hum. Mutat Mutat 36, 222-231

Powell, C.A.*, Kopajtich, R.*, D'Souza, A.R., Rorbach, J., Dallabona, C., Donnini, C., Alston, C.L., Griffin, H., Pyle, A., Chinnery, P.F., Strom, T.M., Meitinger, T., Rodenburg, R.J., Schottmann, G., Schuelke, M., Romain, N., Haller, R., Ferrero, I., Haack, T.B., Taylor, R.W., Prokisch, H.**, Minczuk, M. (2015) Mutations in TRMT5 cause a defect in post-transcriptional modification of mitochondrial tRNA associated with multiple respiratory-chain deficiencies. Am J Hum Genet. 97,319-328 

Coughlin, C.R. Scharer, G.H., Friederich, M.W., Yu, H.C., Geiger, E.A., Creadon-Swindell, G., Collins, A.E., Vanlander, A.V., Coster, R.V., Powell, C.A., Swanson, M.A., Minczuk, M., Van Hove, J.L., Shaikh, T.H. (2015) Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder. J Med Genet. 52,532-540

and more</gtr:impact><gtr:outcomeId>WHQjUZ1sQdT-3</gtr:outcomeId><gtr:partnerContribution>Identification of mutations by next-generation exome sequencing in patients with combined OXPHOS defects</gtr:partnerContribution><gtr:piContribution>We analyse molecular phenotypes associated with mutations in muclaer genes involved in mitochondrial RNA processing and post-transcriptional modification.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Carlo Besta Neurological Institute</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Mitochondrial RNA metabolism and human disease</gtr:description><gtr:id>2E2C6A40-0AF3-4E5D-B2CD-1176254F1318</gtr:id><gtr:impact>Several papers e.g: 

Van Haute L, Dietmann S, Kremer L, Hussain S, Pearce SF, Powell CA, Rorbach J, Lantaff R, Blanco S, Sauer S, Kotzaeridou U, Hoffmann GF, Memari Y, Kolb-Kokocinski A, Durbin R, Mayr JA, Frye M, Prokisch H, Minczuk M.Deficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3. Nat Commun. 2016 Jun 30;7:12039. doi: 10.1038/ncomms12039.

Haack, T.B.*, Kopajtich, R.*, Freisinger, P.*, Wieland, T., Rorbach, J, Nicholls, T.J., Enrico Baruffini, E., Walther, A., Danhauser, K., Zimmermann, F.A., Husain, R.A., Schum, J., Mundy, H., Ferrero, I., Strom, T.M., Meitinger, T., Taylor, R.W., Minczuk, M**., Mayr, J.A., Prokisch, H.** (2013) ELAC2 Mutations Cause a Mitochondrial RNA Processing Defect Associated with Hypertrophic Cardiomyopathy. Am J Hum Genet 93, 211-223

Kopajtich, R.,* Nicholls, T.J.,* Rorbach, J.,* Freisinger, P., Mandel, H., Vanlander, A., Ghezzi, D., Carrozzo, R., Taylor, R.W., Marquard, K., Murayama, K., Wieland, T., Schwarzmayr, T., Mayr, J.A., Pearce, S. F., Powell, C. Saada, A., Ohtake, A., Invernizzi, F., Lamantea, E., Sommerville, E. W., Pyle, A., Chinnery, P. F., Crushell, E., Okazaki, Y., Kohda, M., Kishita, Y., Tokuzawa, Y., Smet, J., R&amp;eacute;gal, L., Lorber, A., Khoury, A., Zeviani, M., Strom, T. M., Meitinger, T., Bertini, E. S., Van Coster, R., Klopstock, T., Haack, T. B., Minczuk, M.,** Prokisch, H.** (-) Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis and encephalopathy Am J Hum Genet 95, 708-20

Vanlander, A.V., Menten, B., Smet, J., De Meirleir, L., Sante, T., De Paepe, B., Seneca, S., Pearce, S.F., Powell, C.A., Vergult, S., Michotte, A., De Latter, E., Vantomme, L., Minczuk, M. and Van Coster, R. (-) Two siblings with homozygous pathogenic splice site mutation in mitochondrial asparaginyl-tRNA synthetase (NARS2) Hum. Mutat Mutat 36, 222-231

Powell, C.A.*, Kopajtich, R.*, D'Souza, A.R., Rorbach, J., Dallabona, C., Donnini, C., Alston, C.L., Griffin, H., Pyle, A., Chinnery, P.F., Strom, T.M., Meitinger, T., Rodenburg, R.J., Schottmann, G., Schuelke, M., Romain, N., Haller, R., Ferrero, I., Haack, T.B., Taylor, R.W., Prokisch, H.**, Minczuk, M. (2015) Mutations in TRMT5 cause a defect in post-transcriptional modification of mitochondrial tRNA associated with multiple respiratory-chain deficiencies. Am J Hum Genet. 97,319-328 

Coughlin, C.R. Scharer, G.H., Friederich, M.W., Yu, H.C., Geiger, E.A., Creadon-Swindell, G., Collins, A.E., Vanlander, A.V., Coster, R.V., Powell, C.A., Swanson, M.A., Minczuk, M., Van Hove, J.L., Shaikh, T.H. (2015) Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder. J Med Genet. 52,532-540

and more</gtr:impact><gtr:outcomeId>WHQjUZ1sQdT-7</gtr:outcomeId><gtr:partnerContribution>Identification of mutations by next-generation exome sequencing in patients with combined OXPHOS defects</gtr:partnerContribution><gtr:piContribution>We analyse molecular phenotypes associated with mutations in muclaer genes involved in mitochondrial RNA processing and post-transcriptional modification.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital Bonn</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Epileptology</gtr:department><gtr:description>Analysis of a novel nuclease in patients presenting combined OXPHOS deficiencies.</gtr:description><gtr:id>82C894CF-FBEB-45B6-9238-70231C9358F1</gtr:id><gtr:impact>The project is multidisciplinary as it involves collaboration between neurologists and molecular biologists.
 
Two papers published:
Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease.
Kornblum C, Nicholls TJ, Haack TB, Sch&amp;ouml;ler S, Peeva V, Danhauser K, Hallmann K, Zsurka G, Rorbach J, Iuso A, Wieland T, Sciacco M, Ronchi D, Comi GP, Moggio M, Quinzii CM, DiMauro S, Calvo SE, Mootha VK, Klopstock T, Strom TM, Meitinger T, Minczuk M, Kunz WS, Prokisch H.
Nat Genet. 2013 Feb;45(2):214-9. doi: 10.1038/ng.2501.

Linear mtDNA fragments and unusual mtDNA rearrangements associated with pathological deficiency of MGME1 exonuclease.
Nicholls TJ, Zsurka G, Peeva V, Sch&amp;ouml;ler S, Szczesny RJ, Cysewski D, Reyes A, Kornblum C, Sciacco M, Moggio M, Dziembowski A, Kunz WS, Minczuk M.
Hum Mol Genet. 2014 Dec 1;23(23):6147-62. doi: 10.1093/hmg/ddu336.

We identified a new disease gene which is now routinely screened in patients with mitochondrial disease</gtr:impact><gtr:outcomeId>VjDbhxkaZ6h-3</gtr:outcomeId><gtr:partnerContribution>following the family clinical history and provided clinical data
identified mutations</gtr:partnerContribution><gtr:piContribution>In 2010 we identified a novel mitochondrial deoxyribonuclease. In order to understand its function in human mtDNA maintenance we have studied the phenotypes of gene inactivation by RNAi and overexpression and analysed the biochemical activity of the recombinant enzyme.

In 2011 we started a collaboration with five other groups as they had identified a mutation in the coding gene in six individuals from three unrelated families presenting combined OXPHOS deficiency. Currently, we are confirming the phenotypes observed in the RNAi experiments using patient-derived fibroblasts and performing complementation studies. 

New patients identified in 2016</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Zentrum M?nchen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute of Human Genetics</gtr:department><gtr:description>Mitochondrial RNA metabolism and human disease</gtr:description><gtr:id>AB1F4D02-C837-46B7-A866-F2AAACAD08F8</gtr:id><gtr:impact>Several papers e.g: 

Van Haute L, Dietmann S, Kremer L, Hussain S, Pearce SF, Powell CA, Rorbach J, Lantaff R, Blanco S, Sauer S, Kotzaeridou U, Hoffmann GF, Memari Y, Kolb-Kokocinski A, Durbin R, Mayr JA, Frye M, Prokisch H, Minczuk M.Deficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3. Nat Commun. 2016 Jun 30;7:12039. doi: 10.1038/ncomms12039.

Haack, T.B.*, Kopajtich, R.*, Freisinger, P.*, Wieland, T., Rorbach, J, Nicholls, T.J., Enrico Baruffini, E., Walther, A., Danhauser, K., Zimmermann, F.A., Husain, R.A., Schum, J., Mundy, H., Ferrero, I., Strom, T.M., Meitinger, T., Taylor, R.W., Minczuk, M**., Mayr, J.A., Prokisch, H.** (2013) ELAC2 Mutations Cause a Mitochondrial RNA Processing Defect Associated with Hypertrophic Cardiomyopathy. Am J Hum Genet 93, 211-223

Kopajtich, R.,* Nicholls, T.J.,* Rorbach, J.,* Freisinger, P., Mandel, H., Vanlander, A., Ghezzi, D., Carrozzo, R., Taylor, R.W., Marquard, K., Murayama, K., Wieland, T., Schwarzmayr, T., Mayr, J.A., Pearce, S. F., Powell, C. Saada, A., Ohtake, A., Invernizzi, F., Lamantea, E., Sommerville, E. W., Pyle, A., Chinnery, P. F., Crushell, E., Okazaki, Y., Kohda, M., Kishita, Y., Tokuzawa, Y., Smet, J., R&amp;eacute;gal, L., Lorber, A., Khoury, A., Zeviani, M., Strom, T. M., Meitinger, T., Bertini, E. S., Van Coster, R., Klopstock, T., Haack, T. B., Minczuk, M.,** Prokisch, H.** (-) Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis and encephalopathy Am J Hum Genet 95, 708-20

Vanlander, A.V., Menten, B., Smet, J., De Meirleir, L., Sante, T., De Paepe, B., Seneca, S., Pearce, S.F., Powell, C.A., Vergult, S., Michotte, A., De Latter, E., Vantomme, L., Minczuk, M. and Van Coster, R. (-) Two siblings with homozygous pathogenic splice site mutation in mitochondrial asparaginyl-tRNA synthetase (NARS2) Hum. Mutat Mutat 36, 222-231

Powell, C.A.*, Kopajtich, R.*, D'Souza, A.R., Rorbach, J., Dallabona, C., Donnini, C., Alston, C.L., Griffin, H., Pyle, A., Chinnery, P.F., Strom, T.M., Meitinger, T., Rodenburg, R.J., Schottmann, G., Schuelke, M., Romain, N., Haller, R., Ferrero, I., Haack, T.B., Taylor, R.W., Prokisch, H.**, Minczuk, M. (2015) Mutations in TRMT5 cause a defect in post-transcriptional modification of mitochondrial tRNA associated with multiple respiratory-chain deficiencies. Am J Hum Genet. 97,319-328 

Coughlin, C.R. Scharer, G.H., Friederich, M.W., Yu, H.C., Geiger, E.A., Creadon-Swindell, G., Collins, A.E., Vanlander, A.V., Coster, R.V., Powell, C.A., Swanson, M.A., Minczuk, M., Van Hove, J.L., Shaikh, T.H. (2015) Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder. J Med Genet. 52,532-540

and more</gtr:impact><gtr:outcomeId>WHQjUZ1sQdT-1</gtr:outcomeId><gtr:partnerContribution>Identification of mutations by next-generation exome sequencing in patients with combined OXPHOS defects</gtr:partnerContribution><gtr:piContribution>We analyse molecular phenotypes associated with mutations in muclaer genes involved in mitochondrial RNA processing and post-transcriptional modification.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>South Australian Clinical Genetics Service</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Mitochondrial RNA metabolism and human disease</gtr:description><gtr:id>BFEBB381-765F-46B3-A282-9FC0DCE51BF0</gtr:id><gtr:impact>Several papers e.g: 

Van Haute L, Dietmann S, Kremer L, Hussain S, Pearce SF, Powell CA, Rorbach J, Lantaff R, Blanco S, Sauer S, Kotzaeridou U, Hoffmann GF, Memari Y, Kolb-Kokocinski A, Durbin R, Mayr JA, Frye M, Prokisch H, Minczuk M.Deficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3. Nat Commun. 2016 Jun 30;7:12039. doi: 10.1038/ncomms12039.

Haack, T.B.*, Kopajtich, R.*, Freisinger, P.*, Wieland, T., Rorbach, J, Nicholls, T.J., Enrico Baruffini, E., Walther, A., Danhauser, K., Zimmermann, F.A., Husain, R.A., Schum, J., Mundy, H., Ferrero, I., Strom, T.M., Meitinger, T., Taylor, R.W., Minczuk, M**., Mayr, J.A., Prokisch, H.** (2013) ELAC2 Mutations Cause a Mitochondrial RNA Processing Defect Associated with Hypertrophic Cardiomyopathy. Am J Hum Genet 93, 211-223

Kopajtich, R.,* Nicholls, T.J.,* Rorbach, J.,* Freisinger, P., Mandel, H., Vanlander, A., Ghezzi, D., Carrozzo, R., Taylor, R.W., Marquard, K., Murayama, K., Wieland, T., Schwarzmayr, T., Mayr, J.A., Pearce, S. F., Powell, C. Saada, A., Ohtake, A., Invernizzi, F., Lamantea, E., Sommerville, E. W., Pyle, A., Chinnery, P. F., Crushell, E., Okazaki, Y., Kohda, M., Kishita, Y., Tokuzawa, Y., Smet, J., R&amp;eacute;gal, L., Lorber, A., Khoury, A., Zeviani, M., Strom, T. M., Meitinger, T., Bertini, E. S., Van Coster, R., Klopstock, T., Haack, T. B., Minczuk, M.,** Prokisch, H.** (-) Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis and encephalopathy Am J Hum Genet 95, 708-20

Vanlander, A.V., Menten, B., Smet, J., De Meirleir, L., Sante, T., De Paepe, B., Seneca, S., Pearce, S.F., Powell, C.A., Vergult, S., Michotte, A., De Latter, E., Vantomme, L., Minczuk, M. and Van Coster, R. (-) Two siblings with homozygous pathogenic splice site mutation in mitochondrial asparaginyl-tRNA synthetase (NARS2) Hum. Mutat Mutat 36, 222-231

Powell, C.A.*, Kopajtich, R.*, D'Souza, A.R., Rorbach, J., Dallabona, C., Donnini, C., Alston, C.L., Griffin, H., Pyle, A., Chinnery, P.F., Strom, T.M., Meitinger, T., Rodenburg, R.J., Schottmann, G., Schuelke, M., Romain, N., Haller, R., Ferrero, I., Haack, T.B., Taylor, R.W., Prokisch, H.**, Minczuk, M. (2015) Mutations in TRMT5 cause a defect in post-transcriptional modification of mitochondrial tRNA associated with multiple respiratory-chain deficiencies. Am J Hum Genet. 97,319-328 

Coughlin, C.R. Scharer, G.H., Friederich, M.W., Yu, H.C., Geiger, E.A., Creadon-Swindell, G., Collins, A.E., Vanlander, A.V., Coster, R.V., Powell, C.A., Swanson, M.A., Minczuk, M., Van Hove, J.L., Shaikh, T.H. (2015) Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder. J Med Genet. 52,532-540

and more</gtr:impact><gtr:outcomeId>WHQjUZ1sQdT-6</gtr:outcomeId><gtr:partnerContribution>Identification of mutations by next-generation exome sequencing in patients with combined OXPHOS defects</gtr:partnerContribution><gtr:piContribution>We analyse molecular phenotypes associated with mutations in muclaer genes involved in mitochondrial RNA processing and post-transcriptional modification.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Columbia University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>College of Physicians &amp; Surgeons</gtr:department><gtr:description>Analysis of a novel nuclease in patients presenting combined OXPHOS deficiencies.</gtr:description><gtr:id>4012C857-67F3-47DE-A7C5-6CA08933AD52</gtr:id><gtr:impact>The project is multidisciplinary as it involves collaboration between neurologists and molecular biologists.
 
Two papers published:
Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease.
Kornblum C, Nicholls TJ, Haack TB, Sch&amp;ouml;ler S, Peeva V, Danhauser K, Hallmann K, Zsurka G, Rorbach J, Iuso A, Wieland T, Sciacco M, Ronchi D, Comi GP, Moggio M, Quinzii CM, DiMauro S, Calvo SE, Mootha VK, Klopstock T, Strom TM, Meitinger T, Minczuk M, Kunz WS, Prokisch H.
Nat Genet. 2013 Feb;45(2):214-9. doi: 10.1038/ng.2501.

Linear mtDNA fragments and unusual mtDNA rearrangements associated with pathological deficiency of MGME1 exonuclease.
Nicholls TJ, Zsurka G, Peeva V, Sch&amp;ouml;ler S, Szczesny RJ, Cysewski D, Reyes A, Kornblum C, Sciacco M, Moggio M, Dziembowski A, Kunz WS, Minczuk M.
Hum Mol Genet. 2014 Dec 1;23(23):6147-62. doi: 10.1093/hmg/ddu336.

We identified a new disease gene which is now routinely screened in patients with mitochondrial disease</gtr:impact><gtr:outcomeId>VjDbhxkaZ6h-1</gtr:outcomeId><gtr:partnerContribution>following the family clinical history and provided clinical data
identified mutations</gtr:partnerContribution><gtr:piContribution>In 2010 we identified a novel mitochondrial deoxyribonuclease. In order to understand its function in human mtDNA maintenance we have studied the phenotypes of gene inactivation by RNAi and overexpression and analysed the biochemical activity of the recombinant enzyme.

In 2011 we started a collaboration with five other groups as they had identified a mutation in the coding gene in six individuals from three unrelated families presenting combined OXPHOS deficiency. Currently, we are confirming the phenotypes observed in the RNAi experiments using patient-derived fibroblasts and performing complementation studies. 

New patients identified in 2016</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biomedical Sciences</gtr:department><gtr:description>Mitochondrial RNA metabolism and human disease</gtr:description><gtr:id>DA718362-8CE8-4EAF-9605-6D3C7D5711D3</gtr:id><gtr:impact>Several papers e.g: 

Van Haute L, Dietmann S, Kremer L, Hussain S, Pearce SF, Powell CA, Rorbach J, Lantaff R, Blanco S, Sauer S, Kotzaeridou U, Hoffmann GF, Memari Y, Kolb-Kokocinski A, Durbin R, Mayr JA, Frye M, Prokisch H, Minczuk M.Deficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3. Nat Commun. 2016 Jun 30;7:12039. doi: 10.1038/ncomms12039.

Haack, T.B.*, Kopajtich, R.*, Freisinger, P.*, Wieland, T., Rorbach, J, Nicholls, T.J., Enrico Baruffini, E., Walther, A., Danhauser, K., Zimmermann, F.A., Husain, R.A., Schum, J., Mundy, H., Ferrero, I., Strom, T.M., Meitinger, T., Taylor, R.W., Minczuk, M**., Mayr, J.A., Prokisch, H.** (2013) ELAC2 Mutations Cause a Mitochondrial RNA Processing Defect Associated with Hypertrophic Cardiomyopathy. Am J Hum Genet 93, 211-223

Kopajtich, R.,* Nicholls, T.J.,* Rorbach, J.,* Freisinger, P., Mandel, H., Vanlander, A., Ghezzi, D., Carrozzo, R., Taylor, R.W., Marquard, K., Murayama, K., Wieland, T., Schwarzmayr, T., Mayr, J.A., Pearce, S. F., Powell, C. Saada, A., Ohtake, A., Invernizzi, F., Lamantea, E., Sommerville, E. W., Pyle, A., Chinnery, P. F., Crushell, E., Okazaki, Y., Kohda, M., Kishita, Y., Tokuzawa, Y., Smet, J., R&amp;eacute;gal, L., Lorber, A., Khoury, A., Zeviani, M., Strom, T. M., Meitinger, T., Bertini, E. S., Van Coster, R., Klopstock, T., Haack, T. B., Minczuk, M.,** Prokisch, H.** (-) Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis and encephalopathy Am J Hum Genet 95, 708-20

Vanlander, A.V., Menten, B., Smet, J., De Meirleir, L., Sante, T., De Paepe, B., Seneca, S., Pearce, S.F., Powell, C.A., Vergult, S., Michotte, A., De Latter, E., Vantomme, L., Minczuk, M. and Van Coster, R. (-) Two siblings with homozygous pathogenic splice site mutation in mitochondrial asparaginyl-tRNA synthetase (NARS2) Hum. Mutat Mutat 36, 222-231

Powell, C.A.*, Kopajtich, R.*, D'Souza, A.R., Rorbach, J., Dallabona, C., Donnini, C., Alston, C.L., Griffin, H., Pyle, A., Chinnery, P.F., Strom, T.M., Meitinger, T., Rodenburg, R.J., Schottmann, G., Schuelke, M., Romain, N., Haller, R., Ferrero, I., Haack, T.B., Taylor, R.W., Prokisch, H.**, Minczuk, M. (2015) Mutations in TRMT5 cause a defect in post-transcriptional modification of mitochondrial tRNA associated with multiple respiratory-chain deficiencies. Am J Hum Genet. 97,319-328 

Coughlin, C.R. Scharer, G.H., Friederich, M.W., Yu, H.C., Geiger, E.A., Creadon-Swindell, G., Collins, A.E., Vanlander, A.V., Coster, R.V., Powell, C.A., Swanson, M.A., Minczuk, M., Van Hove, J.L., Shaikh, T.H. (2015) Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder. J Med Genet. 52,532-540

and more</gtr:impact><gtr:outcomeId>WHQjUZ1sQdT-2</gtr:outcomeId><gtr:partnerContribution>Identification of mutations by next-generation exome sequencing in patients with combined OXPHOS defects</gtr:partnerContribution><gtr:piContribution>We analyse molecular phenotypes associated with mutations in muclaer genes involved in mitochondrial RNA processing and post-transcriptional modification.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Radboud University Nijmegen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Mitochondrial RNA metabolism and human disease</gtr:description><gtr:id>1EF58BED-5FB6-484B-950D-882D1D6B94F1</gtr:id><gtr:impact>Several papers e.g: 

Van Haute L, Dietmann S, Kremer L, Hussain S, Pearce SF, Powell CA, Rorbach J, Lantaff R, Blanco S, Sauer S, Kotzaeridou U, Hoffmann GF, Memari Y, Kolb-Kokocinski A, Durbin R, Mayr JA, Frye M, Prokisch H, Minczuk M.Deficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3. Nat Commun. 2016 Jun 30;7:12039. doi: 10.1038/ncomms12039.

Haack, T.B.*, Kopajtich, R.*, Freisinger, P.*, Wieland, T., Rorbach, J, Nicholls, T.J., Enrico Baruffini, E., Walther, A., Danhauser, K., Zimmermann, F.A., Husain, R.A., Schum, J., Mundy, H., Ferrero, I., Strom, T.M., Meitinger, T., Taylor, R.W., Minczuk, M**., Mayr, J.A., Prokisch, H.** (2013) ELAC2 Mutations Cause a Mitochondrial RNA Processing Defect Associated with Hypertrophic Cardiomyopathy. Am J Hum Genet 93, 211-223

Kopajtich, R.,* Nicholls, T.J.,* Rorbach, J.,* Freisinger, P., Mandel, H., Vanlander, A., Ghezzi, D., Carrozzo, R., Taylor, R.W., Marquard, K., Murayama, K., Wieland, T., Schwarzmayr, T., Mayr, J.A., Pearce, S. F., Powell, C. Saada, A., Ohtake, A., Invernizzi, F., Lamantea, E., Sommerville, E. W., Pyle, A., Chinnery, P. F., Crushell, E., Okazaki, Y., Kohda, M., Kishita, Y., Tokuzawa, Y., Smet, J., R&amp;eacute;gal, L., Lorber, A., Khoury, A., Zeviani, M., Strom, T. M., Meitinger, T., Bertini, E. S., Van Coster, R., Klopstock, T., Haack, T. B., Minczuk, M.,** Prokisch, H.** (-) Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis and encephalopathy Am J Hum Genet 95, 708-20

Vanlander, A.V., Menten, B., Smet, J., De Meirleir, L., Sante, T., De Paepe, B., Seneca, S., Pearce, S.F., Powell, C.A., Vergult, S., Michotte, A., De Latter, E., Vantomme, L., Minczuk, M. and Van Coster, R. (-) Two siblings with homozygous pathogenic splice site mutation in mitochondrial asparaginyl-tRNA synthetase (NARS2) Hum. Mutat Mutat 36, 222-231

Powell, C.A.*, Kopajtich, R.*, D'Souza, A.R., Rorbach, J., Dallabona, C., Donnini, C., Alston, C.L., Griffin, H., Pyle, A., Chinnery, P.F., Strom, T.M., Meitinger, T., Rodenburg, R.J., Schottmann, G., Schuelke, M., Romain, N., Haller, R., Ferrero, I., Haack, T.B., Taylor, R.W., Prokisch, H.**, Minczuk, M. (2015) Mutations in TRMT5 cause a defect in post-transcriptional modification of mitochondrial tRNA associated with multiple respiratory-chain deficiencies. Am J Hum Genet. 97,319-328 

Coughlin, C.R. Scharer, G.H., Friederich, M.W., Yu, H.C., Geiger, E.A., Creadon-Swindell, G., Collins, A.E., Vanlander, A.V., Coster, R.V., Powell, C.A., Swanson, M.A., Minczuk, M., Van Hove, J.L., Shaikh, T.H. (2015) Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder. J Med Genet. 52,532-540

and more</gtr:impact><gtr:outcomeId>WHQjUZ1sQdT-8</gtr:outcomeId><gtr:partnerContribution>Identification of mutations by next-generation exome sequencing in patients with combined OXPHOS defects</gtr:partnerContribution><gtr:piContribution>We analyse molecular phenotypes associated with mutations in muclaer genes involved in mitochondrial RNA processing and post-transcriptional modification.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Functional Genomics Unit</gtr:department><gtr:description>RNA polyadenylation in the maintenance and expression of the mitochondrial genome</gtr:description><gtr:id>B686DC02-B58D-492C-9762-8726155CB6BF</gtr:id><gtr:impact>finantial support</gtr:impact><gtr:outcomeId>L7ngfiWPzzq-1</gtr:outcomeId><gtr:partnerContribution>Next-generation sequencing and analysis of mitochondrial RNA</gtr:partnerContribution><gtr:piContribution>Establishing how poly(A) tails regulate mt-RNA abundance and mitochondrial protein synthesis 
Identifying novel proteins that play a role in mitochondrial poly(A) tail metabolism
Determining whether poly(U) extensions play a role in RNA surveillance and/or turnover in human mitochondria</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medical Sciences</gtr:department><gtr:description>Mitochondrial RNA metabolism and human disease</gtr:description><gtr:id>0EC083AD-56D2-4C92-8405-BF9D5C1459C5</gtr:id><gtr:impact>Several papers e.g: 

Van Haute L, Dietmann S, Kremer L, Hussain S, Pearce SF, Powell CA, Rorbach J, Lantaff R, Blanco S, Sauer S, Kotzaeridou U, Hoffmann GF, Memari Y, Kolb-Kokocinski A, Durbin R, Mayr JA, Frye M, Prokisch H, Minczuk M.Deficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3. Nat Commun. 2016 Jun 30;7:12039. doi: 10.1038/ncomms12039.

Haack, T.B.*, Kopajtich, R.*, Freisinger, P.*, Wieland, T., Rorbach, J, Nicholls, T.J., Enrico Baruffini, E., Walther, A., Danhauser, K., Zimmermann, F.A., Husain, R.A., Schum, J., Mundy, H., Ferrero, I., Strom, T.M., Meitinger, T., Taylor, R.W., Minczuk, M**., Mayr, J.A., Prokisch, H.** (2013) ELAC2 Mutations Cause a Mitochondrial RNA Processing Defect Associated with Hypertrophic Cardiomyopathy. Am J Hum Genet 93, 211-223

Kopajtich, R.,* Nicholls, T.J.,* Rorbach, J.,* Freisinger, P., Mandel, H., Vanlander, A., Ghezzi, D., Carrozzo, R., Taylor, R.W., Marquard, K., Murayama, K., Wieland, T., Schwarzmayr, T., Mayr, J.A., Pearce, S. F., Powell, C. Saada, A., Ohtake, A., Invernizzi, F., Lamantea, E., Sommerville, E. W., Pyle, A., Chinnery, P. F., Crushell, E., Okazaki, Y., Kohda, M., Kishita, Y., Tokuzawa, Y., Smet, J., R&amp;eacute;gal, L., Lorber, A., Khoury, A., Zeviani, M., Strom, T. M., Meitinger, T., Bertini, E. S., Van Coster, R., Klopstock, T., Haack, T. B., Minczuk, M.,** Prokisch, H.** (-) Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis and encephalopathy Am J Hum Genet 95, 708-20

Vanlander, A.V., Menten, B., Smet, J., De Meirleir, L., Sante, T., De Paepe, B., Seneca, S., Pearce, S.F., Powell, C.A., Vergult, S., Michotte, A., De Latter, E., Vantomme, L., Minczuk, M. and Van Coster, R. (-) Two siblings with homozygous pathogenic splice site mutation in mitochondrial asparaginyl-tRNA synthetase (NARS2) Hum. Mutat Mutat 36, 222-231

Powell, C.A.*, Kopajtich, R.*, D'Souza, A.R., Rorbach, J., Dallabona, C., Donnini, C., Alston, C.L., Griffin, H., Pyle, A., Chinnery, P.F., Strom, T.M., Meitinger, T., Rodenburg, R.J., Schottmann, G., Schuelke, M., Romain, N., Haller, R., Ferrero, I., Haack, T.B., Taylor, R.W., Prokisch, H.**, Minczuk, M. (2015) Mutations in TRMT5 cause a defect in post-transcriptional modification of mitochondrial tRNA associated with multiple respiratory-chain deficiencies. Am J Hum Genet. 97,319-328 

Coughlin, C.R. Scharer, G.H., Friederich, M.W., Yu, H.C., Geiger, E.A., Creadon-Swindell, G., Collins, A.E., Vanlander, A.V., Coster, R.V., Powell, C.A., Swanson, M.A., Minczuk, M., Van Hove, J.L., Shaikh, T.H. (2015) Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder. J Med Genet. 52,532-540

and more</gtr:impact><gtr:outcomeId>WHQjUZ1sQdT-4</gtr:outcomeId><gtr:partnerContribution>Identification of mutations by next-generation exome sequencing in patients with combined OXPHOS defects</gtr:partnerContribution><gtr:piContribution>We analyse molecular phenotypes associated with mutations in muclaer genes involved in mitochondrial RNA processing and post-transcriptional modification.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Human Genetics</gtr:department><gtr:description>Analysis of a novel nuclease in patients presenting combined OXPHOS deficiencies.</gtr:description><gtr:id>6B7DD7B6-5FCF-46FE-97B0-26BF2DCC1015</gtr:id><gtr:impact>The project is multidisciplinary as it involves collaboration between neurologists and molecular biologists.
 
Two papers published:
Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease.
Kornblum C, Nicholls TJ, Haack TB, Sch&amp;ouml;ler S, Peeva V, Danhauser K, Hallmann K, Zsurka G, Rorbach J, Iuso A, Wieland T, Sciacco M, Ronchi D, Comi GP, Moggio M, Quinzii CM, DiMauro S, Calvo SE, Mootha VK, Klopstock T, Strom TM, Meitinger T, Minczuk M, Kunz WS, Prokisch H.
Nat Genet. 2013 Feb;45(2):214-9. doi: 10.1038/ng.2501.

Linear mtDNA fragments and unusual mtDNA rearrangements associated with pathological deficiency of MGME1 exonuclease.
Nicholls TJ, Zsurka G, Peeva V, Sch&amp;ouml;ler S, Szczesny RJ, Cysewski D, Reyes A, Kornblum C, Sciacco M, Moggio M, Dziembowski A, Kunz WS, Minczuk M.
Hum Mol Genet. 2014 Dec 1;23(23):6147-62. doi: 10.1093/hmg/ddu336.

We identified a new disease gene which is now routinely screened in patients with mitochondrial disease</gtr:impact><gtr:outcomeId>VjDbhxkaZ6h-4</gtr:outcomeId><gtr:partnerContribution>following the family clinical history and provided clinical data
identified mutations</gtr:partnerContribution><gtr:piContribution>In 2010 we identified a novel mitochondrial deoxyribonuclease. In order to understand its function in human mtDNA maintenance we have studied the phenotypes of gene inactivation by RNAi and overexpression and analysed the biochemical activity of the recombinant enzyme.

In 2011 we started a collaboration with five other groups as they had identified a mutation in the coding gene in six individuals from three unrelated families presenting combined OXPHOS deficiency. Currently, we are confirming the phenotypes observed in the RNAi experiments using patient-derived fibroblasts and performing complementation studies. 

New patients identified in 2016</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Role of mitochondria in HCMV infection</gtr:description><gtr:id>028A0C91-159A-40B4-8FA8-B9ED4DCC3DA4</gtr:id><gtr:impact>publication:
Karniely S, Weekes MP, Antrobus R, Rorbach J, Van Haute L, Umrania Y, Smith DL, Stanton RJ, Minczuk M, Lehner P, Sinclair JH (2016) Human cytomegalovirus infection upregulates the mitochondrial transcription and translation machineries.</gtr:impact><gtr:outcomeId>56e05a14e051b6.17401698-1</gtr:outcomeId><gtr:partnerContribution>Provided HCMV infection model and discovered the link between varial infection and mitochondrial gene expression</gtr:partnerContribution><gtr:piContribution>Provided analysis of mitochondrial function in cellular model of HCMV infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kent</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Analysis of protein localisation depending on mtDNA content</gtr:description><gtr:id>5B44262E-E625-42C2-9C7F-8E48A7F6FB09</gtr:id><gtr:impact>Unknown</gtr:impact><gtr:outcomeId>WeEA3aRV1DM-1</gtr:outcomeId><gtr:partnerContribution>Analysis of protein localisation in conditions of reduced mtDNA copy number</gtr:partnerContribution><gtr:piContribution>Providing inducible human cell line for allowing for controlled reduction of the copy number of mitochondrial DNA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Milan</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>Analysis of a novel nuclease in patients presenting combined OXPHOS deficiencies.</gtr:description><gtr:id>ADEA2082-8F0D-4BA2-B651-E2B62A19E0E0</gtr:id><gtr:impact>The project is multidisciplinary as it involves collaboration between neurologists and molecular biologists.
 
Two papers published:
Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease.
Kornblum C, Nicholls TJ, Haack TB, Sch&amp;ouml;ler S, Peeva V, Danhauser K, Hallmann K, Zsurka G, Rorbach J, Iuso A, Wieland T, Sciacco M, Ronchi D, Comi GP, Moggio M, Quinzii CM, DiMauro S, Calvo SE, Mootha VK, Klopstock T, Strom TM, Meitinger T, Minczuk M, Kunz WS, Prokisch H.
Nat Genet. 2013 Feb;45(2):214-9. doi: 10.1038/ng.2501.

Linear mtDNA fragments and unusual mtDNA rearrangements associated with pathological deficiency of MGME1 exonuclease.
Nicholls TJ, Zsurka G, Peeva V, Sch&amp;ouml;ler S, Szczesny RJ, Cysewski D, Reyes A, Kornblum C, Sciacco M, Moggio M, Dziembowski A, Kunz WS, Minczuk M.
Hum Mol Genet. 2014 Dec 1;23(23):6147-62. doi: 10.1093/hmg/ddu336.

We identified a new disease gene which is now routinely screened in patients with mitochondrial disease</gtr:impact><gtr:outcomeId>VjDbhxkaZ6h-5</gtr:outcomeId><gtr:partnerContribution>following the family clinical history and provided clinical data
identified mutations</gtr:partnerContribution><gtr:piContribution>In 2010 we identified a novel mitochondrial deoxyribonuclease. In order to understand its function in human mtDNA maintenance we have studied the phenotypes of gene inactivation by RNAi and overexpression and analysed the biochemical activity of the recombinant enzyme.

In 2011 we started a collaboration with five other groups as they had identified a mutation in the coding gene in six individuals from three unrelated families presenting combined OXPHOS deficiency. Currently, we are confirming the phenotypes observed in the RNAi experiments using patient-derived fibroblasts and performing complementation studies. 

New patients identified in 2016</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Columbia University Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Mitochondrial RNA metabolism and human disease</gtr:description><gtr:id>03BB062C-84BD-4997-AAFB-30F58BB5500F</gtr:id><gtr:impact>Several papers e.g: 

Van Haute L, Dietmann S, Kremer L, Hussain S, Pearce SF, Powell CA, Rorbach J, Lantaff R, Blanco S, Sauer S, Kotzaeridou U, Hoffmann GF, Memari Y, Kolb-Kokocinski A, Durbin R, Mayr JA, Frye M, Prokisch H, Minczuk M.Deficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3. Nat Commun. 2016 Jun 30;7:12039. doi: 10.1038/ncomms12039.

Haack, T.B.*, Kopajtich, R.*, Freisinger, P.*, Wieland, T., Rorbach, J, Nicholls, T.J., Enrico Baruffini, E., Walther, A., Danhauser, K., Zimmermann, F.A., Husain, R.A., Schum, J., Mundy, H., Ferrero, I., Strom, T.M., Meitinger, T., Taylor, R.W., Minczuk, M**., Mayr, J.A., Prokisch, H.** (2013) ELAC2 Mutations Cause a Mitochondrial RNA Processing Defect Associated with Hypertrophic Cardiomyopathy. Am J Hum Genet 93, 211-223

Kopajtich, R.,* Nicholls, T.J.,* Rorbach, J.,* Freisinger, P., Mandel, H., Vanlander, A., Ghezzi, D., Carrozzo, R., Taylor, R.W., Marquard, K., Murayama, K., Wieland, T., Schwarzmayr, T., Mayr, J.A., Pearce, S. F., Powell, C. Saada, A., Ohtake, A., Invernizzi, F., Lamantea, E., Sommerville, E. W., Pyle, A., Chinnery, P. F., Crushell, E., Okazaki, Y., Kohda, M., Kishita, Y., Tokuzawa, Y., Smet, J., R&amp;eacute;gal, L., Lorber, A., Khoury, A., Zeviani, M., Strom, T. M., Meitinger, T., Bertini, E. S., Van Coster, R., Klopstock, T., Haack, T. B., Minczuk, M.,** Prokisch, H.** (-) Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis and encephalopathy Am J Hum Genet 95, 708-20

Vanlander, A.V., Menten, B., Smet, J., De Meirleir, L., Sante, T., De Paepe, B., Seneca, S., Pearce, S.F., Powell, C.A., Vergult, S., Michotte, A., De Latter, E., Vantomme, L., Minczuk, M. and Van Coster, R. (-) Two siblings with homozygous pathogenic splice site mutation in mitochondrial asparaginyl-tRNA synthetase (NARS2) Hum. Mutat Mutat 36, 222-231

Powell, C.A.*, Kopajtich, R.*, D'Souza, A.R., Rorbach, J., Dallabona, C., Donnini, C., Alston, C.L., Griffin, H., Pyle, A., Chinnery, P.F., Strom, T.M., Meitinger, T., Rodenburg, R.J., Schottmann, G., Schuelke, M., Romain, N., Haller, R., Ferrero, I., Haack, T.B., Taylor, R.W., Prokisch, H.**, Minczuk, M. (2015) Mutations in TRMT5 cause a defect in post-transcriptional modification of mitochondrial tRNA associated with multiple respiratory-chain deficiencies. Am J Hum Genet. 97,319-328 

Coughlin, C.R. Scharer, G.H., Friederich, M.W., Yu, H.C., Geiger, E.A., Creadon-Swindell, G., Collins, A.E., Vanlander, A.V., Coster, R.V., Powell, C.A., Swanson, M.A., Minczuk, M., Van Hove, J.L., Shaikh, T.H. (2015) Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder. J Med Genet. 52,532-540

and more</gtr:impact><gtr:outcomeId>WHQjUZ1sQdT-5</gtr:outcomeId><gtr:partnerContribution>Identification of mutations by next-generation exome sequencing in patients with combined OXPHOS defects</gtr:partnerContribution><gtr:piContribution>We analyse molecular phenotypes associated with mutations in muclaer genes involved in mitochondrial RNA processing and post-transcriptional modification.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oslo University Hospital</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of Medical Genetics</gtr:department><gtr:description>Analysis of a novel nuclease in patients presenting combined OXPHOS deficiencies.</gtr:description><gtr:id>5AE598BE-AB78-470B-8FB8-643D4C26C56F</gtr:id><gtr:impact>The project is multidisciplinary as it involves collaboration between neurologists and molecular biologists.
 
Two papers published:
Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease.
Kornblum C, Nicholls TJ, Haack TB, Sch&amp;ouml;ler S, Peeva V, Danhauser K, Hallmann K, Zsurka G, Rorbach J, Iuso A, Wieland T, Sciacco M, Ronchi D, Comi GP, Moggio M, Quinzii CM, DiMauro S, Calvo SE, Mootha VK, Klopstock T, Strom TM, Meitinger T, Minczuk M, Kunz WS, Prokisch H.
Nat Genet. 2013 Feb;45(2):214-9. doi: 10.1038/ng.2501.

Linear mtDNA fragments and unusual mtDNA rearrangements associated with pathological deficiency of MGME1 exonuclease.
Nicholls TJ, Zsurka G, Peeva V, Sch&amp;ouml;ler S, Szczesny RJ, Cysewski D, Reyes A, Kornblum C, Sciacco M, Moggio M, Dziembowski A, Kunz WS, Minczuk M.
Hum Mol Genet. 2014 Dec 1;23(23):6147-62. doi: 10.1093/hmg/ddu336.

We identified a new disease gene which is now routinely screened in patients with mitochondrial disease</gtr:impact><gtr:outcomeId>VjDbhxkaZ6h-6</gtr:outcomeId><gtr:partnerContribution>following the family clinical history and provided clinical data
identified mutations</gtr:partnerContribution><gtr:piContribution>In 2010 we identified a novel mitochondrial deoxyribonuclease. In order to understand its function in human mtDNA maintenance we have studied the phenotypes of gene inactivation by RNAi and overexpression and analysed the biochemical activity of the recombinant enzyme.

In 2011 we started a collaboration with five other groups as they had identified a mutation in the coding gene in six individuals from three unrelated families presenting combined OXPHOS deficiency. Currently, we are confirming the phenotypes observed in the RNAi experiments using patient-derived fibroblasts and performing complementation studies. 

New patients identified in 2016</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Miami</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Manipulating mtDNA heteroplasmy in vivo using engineered nucleases</gtr:description><gtr:id>5E54E899-21ED-4D55-8785-1075C2479887</gtr:id><gtr:impact>pending, likely to be societal. 

Some protocols for generation of mtZFN published:
Gammage PA, Van Haute L, Minczuk M.
Engineered mtZFNs for Manipulation of Human Mitochondrial DNA Heteroplasmy.
Methods Mol Biol. 2016;1351:145-62. doi: 10.1007/978-1-4939-3040-1_11

Vectors available at Addgen</gtr:impact><gtr:outcomeId>56e05147522914.16806441-2</gtr:outcomeId><gtr:partnerContribution>Providing mouse model, help and expertise in mtZFN research that may led to generation of pre-clinical data useful for a development of an effective treatment of mtDNA disease in the future.</gtr:partnerContribution><gtr:piContribution>We have generated a mtZFN library specific to mtDNA mutation present in a model strain, tested them in mouse embryonic fibroblasts (MEF) from the mt-tRNAAla mouse line and identified constructs capable of effective reduction of mutant load. We will deliver these ZFNs affected mice with optimal mtZFN constructs by organtropic, recombinant adeno-associated viruses (AAVs).

We will also manipulte mtDNA heteroplasmy in germline using mtZFN and mitoTALENs (the latter obtained in collaboration with Uni of Miami)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Research and Development AstraZeneca</gtr:department><gtr:description>Mitochondria in drug toxicity</gtr:description><gtr:id>55884671-780E-4307-B498-941BEB7537F4</gtr:id><gtr:impact>ongoing</gtr:impact><gtr:outcomeId>5463853f257bb0.51060823-1</gtr:outcomeId><gtr:partnerContribution>Providing access to a high-throughput measurements of mitochondrial function.</gtr:partnerContribution><gtr:piContribution>Hosting and training a collaborative post-doc</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sangamo Biosciences, Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Designing mitochondrial zinc finger nucleases</gtr:description><gtr:id>47EEDC6C-5050-4E15-BE1E-F8B3C3452FF5</gtr:id><gtr:impact>Several papers e.g.
Minczuk, M., Kolasinska-Zwierz, P., Murphy, M.P., Papworth, M.A. (2010) Construction and testing of engineered zinc-finger proteins for sequence-specific modification of mtDNA. Nat Protoc 5, 342-56

Gammage, P.A., Rorbach, J., Vincent, A.I., Rebar, E.J, Minczuk, M. (2014) Mitochondrially-targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations. EMBO Mol Med 6, 458-466
In this paper we are reporting an improved version of mitochondrially-targeted engineered zinc-finger nucleases (mtZFNs) designed to eliminate human mtDNA molecules with pathogenic point mutations and large-scale deletions. Expression of mtZFNs successfully led to a reduction in the mutant mtDNA haplotype load, and subsequent repopulation of wildtype mtDNA was found to restore mitochondrial respiratory function in a cybrid cell model. This research was highlighted by: Moraes C. T. (2014) A magic bullet to specifically eliminate mutated mitochondrial genomes from patients' cells. EMBO Mol. Med. 6, 434-435

Gammage, P.A., Van Haute, L., Minczuk, M. (2015) Engineered mtZFNs for manipulation of human mitochondrial DNA heteroplasmy Methods Mol. Biol. Mitochondrial DNA McKenzie, M (Ed)</gtr:impact><gtr:outcomeId>5463869246b906.03576252-1</gtr:outcomeId><gtr:partnerContribution>Assembling and validating zinc finger proteins</gtr:partnerContribution><gtr:piContribution>Developing mitochondrially-targeted engineered nucleases to eliminate human mtDNA molecules with pathogenic point mutations and large-scale deletions</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>Analysis of a novel nuclease in patients presenting combined OXPHOS deficiencies.</gtr:description><gtr:id>776CB0AC-610A-496E-AF14-04009410B6C4</gtr:id><gtr:impact>The project is multidisciplinary as it involves collaboration between neurologists and molecular biologists.
 
Two papers published:
Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease.
Kornblum C, Nicholls TJ, Haack TB, Sch&amp;ouml;ler S, Peeva V, Danhauser K, Hallmann K, Zsurka G, Rorbach J, Iuso A, Wieland T, Sciacco M, Ronchi D, Comi GP, Moggio M, Quinzii CM, DiMauro S, Calvo SE, Mootha VK, Klopstock T, Strom TM, Meitinger T, Minczuk M, Kunz WS, Prokisch H.
Nat Genet. 2013 Feb;45(2):214-9. doi: 10.1038/ng.2501.

Linear mtDNA fragments and unusual mtDNA rearrangements associated with pathological deficiency of MGME1 exonuclease.
Nicholls TJ, Zsurka G, Peeva V, Sch&amp;ouml;ler S, Szczesny RJ, Cysewski D, Reyes A, Kornblum C, Sciacco M, Moggio M, Dziembowski A, Kunz WS, Minczuk M.
Hum Mol Genet. 2014 Dec 1;23(23):6147-62. doi: 10.1093/hmg/ddu336.

We identified a new disease gene which is now routinely screened in patients with mitochondrial disease</gtr:impact><gtr:outcomeId>VjDbhxkaZ6h-2</gtr:outcomeId><gtr:partnerContribution>following the family clinical history and provided clinical data
identified mutations</gtr:partnerContribution><gtr:piContribution>In 2010 we identified a novel mitochondrial deoxyribonuclease. In order to understand its function in human mtDNA maintenance we have studied the phenotypes of gene inactivation by RNAi and overexpression and analysed the biochemical activity of the recombinant enzyme.

In 2011 we started a collaboration with five other groups as they had identified a mutation in the coding gene in six individuals from three unrelated families presenting combined OXPHOS deficiency. Currently, we are confirming the phenotypes observed in the RNAi experiments using patient-derived fibroblasts and performing complementation studies. 

New patients identified in 2016</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute for the Biology of Ageing</gtr:department><gtr:description>Manipulating mtDNA heteroplasmy in vivo using engineered nucleases</gtr:description><gtr:id>B043D775-C8F5-4A88-AFB3-03703D179ED5</gtr:id><gtr:impact>pending, likely to be societal. 

Some protocols for generation of mtZFN published:
Gammage PA, Van Haute L, Minczuk M.
Engineered mtZFNs for Manipulation of Human Mitochondrial DNA Heteroplasmy.
Methods Mol Biol. 2016;1351:145-62. doi: 10.1007/978-1-4939-3040-1_11

Vectors available at Addgen</gtr:impact><gtr:outcomeId>56e05147522914.16806441-1</gtr:outcomeId><gtr:partnerContribution>Providing mouse model, help and expertise in mtZFN research that may led to generation of pre-clinical data useful for a development of an effective treatment of mtDNA disease in the future.</gtr:partnerContribution><gtr:piContribution>We have generated a mtZFN library specific to mtDNA mutation present in a model strain, tested them in mouse embryonic fibroblasts (MEF) from the mt-tRNAAla mouse line and identified constructs capable of effective reduction of mutant load. We will deliver these ZFNs affected mice with optimal mtZFN constructs by organtropic, recombinant adeno-associated viruses (AAVs).

We will also manipulte mtDNA heteroplasmy in germline using mtZFN and mitoTALENs (the latter obtained in collaboration with Uni of Miami)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Biglands Green School visit - Cambridge Outreach event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3A74E178-6D61-40C3-AC58-AB6558C6265D</gtr:id><gtr:impact>a short talk about general biology was given, folowed by a discusion about science ith an aim to getting them interested in the sciences, and with a hope of inspiring applications to Cambridge in the future.

not measurable yet</gtr:impact><gtr:outcomeId>en5ybUSXHya</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dissemination of scientific achievements via the internet</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5E2C8E92-A39A-40E6-A705-F17C1F7CAD3A</gtr:id><gtr:impact>Dissemination of scientific achievements and publications to the general public, scientists and others via the Unit's website, Twitter and Facebook.

https:/www.facebook.com/mrc-mbu
Twitter - @MRC_MBU
http://www.mrc-mbu.cam.ac.uk</gtr:impact><gtr:outcomeId>56cf1adb724d99.73631965</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.mrc-mbu.cam.ac.uk/people/michal-minczuk</gtr:url><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge University Widening Participation Programme</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>188B7A5A-9EC4-4C19-ACE0-932FC629B8BB</gtr:id><gtr:impact>PhD student (Payam Gammage) gave a talk to 25 FE college students (doing their A levels) on life as a graduate student at Cambridge and science the MBU. Venue: St. John's College, Cambridge.

Interaction from interested A level students.</gtr:impact><gtr:outcomeId>54087f5b6d6021.04972625</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture at Clare College Outreach summer school</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6ACF5B78-F505-42AC-A5E2-13E3778C3DAA</gtr:id><gtr:impact>A graduate student gave a lecture on University/MRC life at the Clare College Outreach summer school.

Increased awareness amongst students considering University courses.</gtr:impact><gtr:outcomeId>53907cee1aedb4.48883544</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit of Japanese medical students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7385CD0E-5771-4A0E-9D8A-6EBEC969885D</gtr:id><gtr:impact>Visit to Michal Minczuk's laboratory by Japanese medical students. Four members of the research group participated, giving an insight into the work of the Unit, the laboratory and answering questions from the students. Impact - increased awareness.</gtr:impact><gtr:outcomeId>56cf16fea9e001.53455097</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>&quot;Work in Progress&quot; talk to the Selwyn College MCR Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7BECE093-C19B-4573-A419-0DC98651887A</gtr:id><gtr:impact>A graduate student was invited to give an overview of her studies and her life as a graduate student of the University of Cambridge/MRC MBU.

.</gtr:impact><gtr:outcomeId>53907c3153ec75.49065714</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Padova, Italy</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D836B0A5-9C8D-42A2-892E-106AE17855A8</gtr:id><gtr:impact>Mitochondrial Biology and Genetics Lecture Series: joint initiative between the Galilean School of Higher Education and PhD Courses in Biosciences and Biomedical Sciences of the University of Padova.</gtr:impact><gtr:outcomeId>56cf1784bf92c7.58084117</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentations during the MRC Centenary Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5B83BBDF-FC89-4B11-8A5B-E311702772D2</gtr:id><gtr:impact>Members of the public attended the Unit's open day to celebrate the MRC's Centenary.

Increased awareness and interest.</gtr:impact><gtr:outcomeId>53907c90d07645.10206801</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work Experience</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6735576B-2E11-4F94-AFD2-8A3D094A747C</gtr:id><gtr:impact>Visit by three Year 10 students (age 15) to the Unit for a week each - work experience/shadowing in various research groups/environments, chaperoned throughout by individual members of the Unit. Presentation by the visitors at the end of their week.</gtr:impact><gtr:outcomeId>58c16118eabbb7.65760418</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SET for BRITAIN</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EF31E385-D6B7-4EB3-A7F1-A70C5ACBF2E0</gtr:id><gtr:impact>Exhibition of posters by early-career research scientists, engineers and mathematicians. By competition. MBU participant: Sarah Pearce.

SET for BRITAIN exists to raise the profile of Britain's early-stage researchers at Westminster by engaging Members of both Houses of Parliament with current science, engineering and mathematics research being undertaken in the UK, especially that by their local constituents and in their local University. Few of them have science or technology degrees, but around 100 Parliamentarians usually attend during the day.</gtr:impact><gtr:outcomeId>56cf196554e405.35673347</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.setforbritain.org.uk/2016event.asp</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Norwood School</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B9C03A4B-BEEA-44D2-A253-EFAAEC0E33D7</gtr:id><gtr:impact>Visit to the lab by three year 13 students along with their teacher to discuss the concepts and practicalities of gel electrophoresis, gene technology, and gene manipulation. 

Impact: increased awareness</gtr:impact><gtr:outcomeId>56cf17ce66e535.32357034</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Clare College STEM Outreach Lecture Series</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5AB283B6-F24E-4893-9C54-85DAD40DC24A</gtr:id><gtr:impact>A graduate student participated in a series of lectures aimed at undergraduates/summer students of the University of Cambridge

Greater awareness of the Unit's activities.</gtr:impact><gtr:outcomeId>53907d46dd6719.25117875</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0032EBD6-85FB-42FF-9E48-D29F82EAF32A</gtr:id><gtr:impact>Presentations of posters, explanations of mitochondrial processes, movies, interaction with members of the public.

Interest in the Unit's open day.</gtr:impact><gtr:outcomeId>53907bc3b1cd59.81659574</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Graduate Research Forum</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>38079C55-77F5-4775-8A36-DAB867E9CBD7</gtr:id><gtr:impact>talko on general themes in mitochondrial research, the importance of understanding mitochondrial processes (as a key factor in the pathogenesis of many diseases and also in general health/ageing), and on research in our group.

not measurable yet</gtr:impact><gtr:outcomeId>V3BgxwsLqCr</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC MBU Annual Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1735B426-3582-41D0-8315-56643CC463B9</gtr:id><gtr:impact>Overview of work at the MRC MBU; explanations of how mitochondrial dysfunction causes mitochondrial diseases. Audience: Secondary school students, tutors, general public and scientists from neighbouring institutes. Impact: increased awareness.</gtr:impact><gtr:outcomeId>56cf164963bba3.18820020</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.mrc-mbu.cam.ac.uk/news/2335/open-day-2015</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Clare College - Gillespie Conferencing Centre</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EA1FDF83-A761-4CE3-B144-09769E69BAFD</gtr:id><gtr:impact>To give advice and share experiences of undergraduate and graduate study with a group of aspiring 17-18 year old biologists (largely Oxbridge applicants) from a deprived area of East London.

not measurable yet</gtr:impact><gtr:outcomeId>Y7K5qkgspBz</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Opportunities Ahead</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DA4ED88D-8AE0-42A2-BA6F-E4DA5804CCD3</gtr:id><gtr:impact>The event is aimed at school students in years 5 &amp;amp; 6 in the morning followed by students from secondary schools, sixth-forms, recent school and college leavers and parents in the afternoon. The idea is to showcase the wide variety of companies in the Cambridge area and get young people excited about their future.

Signpost 2 Skills is a new service designed to guide students from education and into working life by bringing employers into schools and students into businesses. It is funded by the Greater Cambridge Greater Peterborough LEP and the Greater Cambridge City Deal, and delivered by social enterprise, Form the Future.</gtr:impact><gtr:outcomeId>58c161e2e35109.21468809</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.mrc-mbu.cam.ac.uk/news/2768/opportunities-ahead-careers-fair-cambridge</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>FEBS YTF</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Federation of European Biochemical Societies (FEBS)</gtr:fundingOrg><gtr:id>5E16BFE0-D027-4CE5-ABF9-3F4C6FC7D79F</gtr:id><gtr:outcomeId>cuBiBTjKStV</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Methods for genetic transformation of mitochondria: providing tools for studying mitochondrial myopathies</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>2225033B-5EF9-4EE1-9D98-E50DAACF96A2</gtr:id><gtr:outcomeId>Nds5scsmJKa0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Functional Genomics Unit</gtr:department><gtr:description>CGAT pump priming proposal</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>21671DF0-511A-4CFD-882F-B230286DE54D</gtr:id><gtr:outcomeId>JYDd84KBZUq</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biochemical Society General Travel Grant</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Biochemical Society</gtr:fundingOrg><gtr:id>89590DF4-AC2C-4F8C-8D9C-16FEA3249E8D</gtr:id><gtr:outcomeId>58c997802ca469.45700411</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2017-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clare college - travel grant</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>ABE43596-6F9A-4C24-97E2-37FDCFB37AC3</gtr:id><gtr:outcomeId>Q35py4F4Xrm</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>85000</gtr:amountPounds><gtr:country>Portugal, Portuguese Republic</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>GAABA</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Portuguese Foundation for Science and Technology (Portugal)</gtr:fundingOrg><gtr:id>C734023A-01D0-4F91-A0D2-DA1BB47AA790</gtr:id><gtr:outcomeId>56e05513e8a600.84483842</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7645</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EMBO Short Term fellowship</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:fundingRef>ASTF 564 - 2015</gtr:fundingRef><gtr:id>80D95367-66B7-4D02-A63C-ACBB5560C8DA</gtr:id><gtr:outcomeId>56e05598554156.30800177</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Homerton College Research Grant</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>BDD4D32E-98D2-4A71-AB77-8865D5BF685B</gtr:id><gtr:outcomeId>58ca6373ee7667.49076797</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>273000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>REMIX ITN</gtr:description><gtr:end>2020-10-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>102FF82E-EB9D-4168-AB0C-617E78C1B3F8</gtr:id><gtr:outcomeId>58c9179a815853.37276480</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1060</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Boehringer Ingelheim Fonds</gtr:department><gtr:description>Boehringer Ingelheim Fonds Travel Grant</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Boehringer Ingelheim</gtr:fundingOrg><gtr:id>36CF5293-396C-4015-912D-FBD838F8A115</gtr:id><gtr:outcomeId>58c997d6067d02.34054230</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Long Term Fellowship</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>D4C28BCE-4F68-4495-A8B9-69B0C187AF91</gtr:id><gtr:outcomeId>DAnbneeWCPQ</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Methods for delivering non-mitochondrial proteins to mitochondria are provided. Also provided are nucleic acid constructs comprising a coding sequence encoding a DNA- binding polypeptide, fused to a mitochondrial targeting sequence (MTS) and a nuclear export signal (NES), and the encoded proteins. The construct successfully delivers DNA binding proteins to the mitochondrion. A chimeric methylase based on the above construct is successfully delivered to mitochondria, resulting in modification of mtDNA.</gtr:description><gtr:grantRef>MC_U105697135</gtr:grantRef><gtr:id>987F7247-8CFC-40A5-A753-8EE62AE39F4C</gtr:id><gtr:impact>nil</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>54638abe5b0772.92059409</gtr:outcomeId><gtr:patentId>EP1974034 B1</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>POLYPEPTIDE TARGETING TO MITOCHONDRIA</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Pre-clinical approach to treatment of mtDNA disease</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B0AA9EFA-EF1A-4955-8D40-783E6209051C</gtr:id><gtr:outcomeId>56e05c313d06f4.76492050</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Diagnosis of mitochondrial disease</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E42BC3AA-920B-4EC1-A924-F15BF3327D24</gtr:id><gtr:impact>improvements in clinical service delivery via e.g. pre-natal diagnosis</gtr:impact><gtr:outcomeId>56e05ba92f57f4.05098165</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Reduced Bisulfite RNA sequencing (RedBS RNA-Seq) that relies on the chemical reduction of f5C to hm5C by NaBH4, with the resulting hm5C being subsequently detected by RNA BS. The second protocol, 5-formylcytosine Chemically Assisted Bisulfite RNA sequencing (fCAB RNA-Seq) is based upon O-ethylhydroxylamine protection of f5C from bisulfite conversion. [Nat. comm Lindsey Van Haute et al. 2016]</gtr:description><gtr:id>9504D652-1654-42B9-BE5A-4A03FE8DDE95</gtr:id><gtr:impact>These two new, straightforward methods allow base-resolution mapping of f5C in transcriptomes and are expected to facilitate the search for new 5-formylated cytosines, reveal their functional role in both cytoplasmic and mitochondrial RNA therefore assist further expansion of epitranscriptome research.</gtr:impact><gtr:outcomeId>58c99994020a63.13994212</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>High-throughput detection of f5C in RNA</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This method is based on SILAC proteomics and sucrose density gradient separation of mitoribosomal subunits</gtr:description><gtr:id>6A37DCCF-9063-44A5-978E-E3B5A08C6C00</gtr:id><gtr:impact>Pending</gtr:impact><gtr:outcomeId>58c99a6c282617.41396074</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Quantitative gradient fractionation mass spectrometry (qGFMS)</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>MPAT-Seq approach allowes to perform the transcriptome-wide parallel assessment of 3' ends of mitochondrial tRNAs.</gtr:description><gtr:id>11F52A6A-55D3-4424-8686-6590AD74C8E1</gtr:id><gtr:impact>The further application of this technique may be useful to determine the regulation of the 3' end RNA metabolism in other studies</gtr:impact><gtr:outcomeId>58c99a2f79a006.64624690</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>MPAT-Seq: Next-generation sequencing-based analysis of RNA polyadenylation</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We reported an improved version of mitochondrially-targeted engineered zinc-finger nucleases (mtZFNs) designed to eliminate human mtDNA molecules with pathogenic point mutations and large-scale deletions. Expression of mtZFNs successfully led to a reduction in the mutant mtDNA haplotype load, and subsequent repopulation of wildtype mtDNA was found to restore mitochondrial respiratory function in a cybrid cell model. This research was highlighted by: Moraes C. T. (2014) A magic bullet to specifically eliminate mutated mitochondrial genomes from patients' cells. EMBO Mol. Med. 6, 434-435

Gammage, P.A., Rorbach, J., Vincent, A.I., Rebar, E.J, Minczuk, M. (2014) Mitochondrially-targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations. EMBO Mol Med 6, 458-466</gtr:description><gtr:id>79B1F50B-3F75-4F16-9663-0CBE339B039F</gtr:id><gtr:impact>Mutations and rearrangements of mitochondrial DNA (mtDNA) are a common cause of human disease, where they often coexist with wildtype mtDNA within a single cell. Mitochondrially targeted engineered zinc finger nucleases (mtZFNs) can phenotypically rescue a severe mtDNAmediated dysfunction and show future therapeutic potential.

 Previously reported mtZFN constructs were redesigned, greatly improving target specificity and allowing their safe use in human mitochondria.

 The capacity of the novel mtZFN design was validated by selectively degrading point mutant mtDNA associated with neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP) and maternally inherited Leigh syndrome (MILS).

 The use of the novel mtZFNs was expanded by selectively degrading mtDNA harbouring a pathogenic largescale deletion associated with adultonset chronic progressive external ophthalmoplegia (CPEO) and, less frequently, KearnsSayre syndrome (KSS) and Pearson's marrow pancreas syndrome.

 Data are provided demonstrating that elimination of deleted, pathogenic mtDNA molecules by mtZFNs is sufficient for full recovery of oxidative phosphorylation in a disease model cell line.</gtr:impact><gtr:outcomeId>546388a9880187.03296315</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Zinc-finger nucleases for manipulation of mtDNA</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://embomolmed.embopress.org/content/6/4/458.long</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E6A3118D-C8C0-4818-ACE6-25B62B0079FB</gtr:id><gtr:title>Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80d9ca41445caf7b2c26ab1405dd5ba2"><gtr:id>80d9ca41445caf7b2c26ab1405dd5ba2</gtr:id><gtr:otherNames>Feichtinger RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5a843e3ba14164.90730981</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23A85D9F-AD20-48EB-880D-19A940F0C091</gtr:id><gtr:title>TRNT1 deficiency: clinical, biochemical and molecular genetic features.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc83a0dc6efeaca84e86c78b2269d90b"><gtr:id>cc83a0dc6efeaca84e86c78b2269d90b</gtr:id><gtr:otherNames>Wedatilake Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>585d6b97566b11.58777544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9E7DD98-82F5-449D-9D64-A5C2B5380723</gtr:id><gtr:title>Polyadenylation in bacteria and organelles.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32c739ac12bf8fb6b582f9ac7f6af3f3"><gtr:id>32c739ac12bf8fb6b582f9ac7f6af3f3</gtr:id><gtr:otherNames>Rorbach J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>546381963d03d1.43956228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41C1BEA4-00A3-4845-8274-00F9D9F9FA2B</gtr:id><gtr:title>Myosin VI-Dependent Actin Cages Encapsulate Parkin-Positive Damaged Mitochondria.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d13cbfa1c2e17b03d7503e9b907759f"><gtr:id>2d13cbfa1c2e17b03d7503e9b907759f</gtr:id><gtr:otherNames>Kruppa AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>5a843f0626d6f4.84581730</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03E45E53-0EF8-4875-A78E-1E851F91F9F0</gtr:id><gtr:title>Maturation of selected human mitochondrial tRNAs requires deadenylation.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e827d1caba95885a1d3939181d2f7ad"><gtr:id>1e827d1caba95885a1d3939181d2f7ad</gtr:id><gtr:otherNames>Pearce SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5a2fd4c28f4e48.74760165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D85574A4-0517-4E6E-AC9E-C7E717B6F65A</gtr:id><gtr:title>VARS2 and TARS2 mutations in patients with mitochondrial encephalomyopathies.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abd492f408cad188f8e2cb568f11b41e"><gtr:id>abd492f408cad188f8e2cb568f11b41e</gtr:id><gtr:otherNames>Diodato D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>546381968d70e2.21431329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12ECDF4E-F5BC-45A7-AD19-8D0C6945E844</gtr:id><gtr:title>C7orf30 is necessary for biogenesis of the large subunit of the mitochondrial ribosome.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32c739ac12bf8fb6b582f9ac7f6af3f3"><gtr:id>32c739ac12bf8fb6b582f9ac7f6af3f3</gtr:id><gtr:otherNames>Rorbach J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56c73c05cf2250.95016974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA9E81DF-83BB-4666-A7F5-BF35ADE6B839</gtr:id><gtr:title>Human mitochondrial ribosomes can switch their structural RNA composition.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32c739ac12bf8fb6b582f9ac7f6af3f3"><gtr:id>32c739ac12bf8fb6b582f9ac7f6af3f3</gtr:id><gtr:otherNames>Rorbach J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>585d36fd218069.12632114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A28BC971-4A99-45F0-8AF4-F21984710DA5</gtr:id><gtr:title>NADH Shuttling Couples Cytosolic Reductive Carboxylation of Glutamine with Glycolysis in Cells with Mitochondrial Dysfunction.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a17271fe07cec6a3ad6c5b9ee6640b43"><gtr:id>a17271fe07cec6a3ad6c5b9ee6640b43</gtr:id><gtr:otherNames>Gaude E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>5a9824d4028309.63753400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48368648-0242-4767-9FC6-8DC020A42EF8</gtr:id><gtr:title>Regulation of Mammalian Mitochondrial Gene Expression: Recent Advances.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e827d1caba95885a1d3939181d2f7ad"><gtr:id>1e827d1caba95885a1d3939181d2f7ad</gtr:id><gtr:otherNames>Pearce SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>58c9983462bd68.43744397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>184F765F-AA97-4AC2-BBF6-A9F8EE3A008D</gtr:id><gtr:title>Two siblings with homozygous pathogenic splice-site variant in mitochondrial asparaginyl-tRNA synthetase (NARS2).</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c40e0ba13871f0acf68ae0ce99373708"><gtr:id>c40e0ba13871f0acf68ae0ce99373708</gtr:id><gtr:otherNames>Vanlander AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>546381972ddf99.52543939</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DAA5C73-4963-417E-9607-058D8944F535</gtr:id><gtr:title>The Pseudouridine Synthase RPUSD4 Is an Essential Component of Mitochondrial RNA Granules.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34ea26d79a4a2e0a12c430bcaa7fd431"><gtr:id>34ea26d79a4a2e0a12c430bcaa7fd431</gtr:id><gtr:otherNames>Zaganelli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5a843de144b098.31075108</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>665868F9-BBEF-4DE5-8460-653F187F8A0D</gtr:id><gtr:title>Construction and testing of engineered zinc-finger proteins for sequence-specific modification of mtDNA.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d383d560f7c020e3b3e59a36dd85c29c"><gtr:id>d383d560f7c020e3b3e59a36dd85c29c</gtr:id><gtr:otherNames>Minczuk M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>546381944b89e0.38404910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90BBCFE7-4FA1-4B33-B2EA-8B5204D9F425</gtr:id><gtr:title>Dealing&amp;nbsp;with&amp;nbsp;an&amp;nbsp;Unconventional&amp;nbsp;Genetic&amp;nbsp;Code&amp;nbsp;in&amp;nbsp; Mitochondria:&amp;nbsp;The&amp;nbsp;Biogenesis&amp;nbsp;and&amp;nbsp;Pathogenic&amp;nbsp; Defects&amp;nbsp;of&amp;nbsp;the&amp;nbsp;5-Formylcytosine&amp;nbsp;Modification&amp;nbsp;in&amp;nbsp; Mitochondrial&amp;nbsp;tRNA.</gtr:title><gtr:parentPublicationTitle>Biomolecules</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccf0eedf7f0400f775fe1203610bd51b"><gtr:id>ccf0eedf7f0400f775fe1203610bd51b</gtr:id><gtr:otherNames>Van Haute L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2218-273X</gtr:issn><gtr:outcomeId>58bea9b45616d5.97030895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>383372A9-9A43-4AFE-8C80-A4499ECF64CB</gtr:id><gtr:title>MRM2 and MRM3 are involved in biogenesis of the large subunit of the mitochondrial ribosome.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32c739ac12bf8fb6b582f9ac7f6af3f3"><gtr:id>32c739ac12bf8fb6b582f9ac7f6af3f3</gtr:id><gtr:otherNames>Rorbach J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>54638197072a23.05782327</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC3CFE44-42E7-47E2-B1FA-701F05F4219C</gtr:id><gtr:title>Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ec2b502593741c521bf9cf3ad681198"><gtr:id>7ec2b502593741c521bf9cf3ad681198</gtr:id><gtr:otherNames>Coughlin CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>55b8d024b66a25.01433002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C2EE392-08EF-46C7-AD07-8287D9A3B307</gtr:id><gtr:title>Macropinocytic entry of isolated mitochondria in epidermal growth factor-activated human osteosarcoma cells.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77cbbeb2df4727a09b083792f5e24de0"><gtr:id>77cbbeb2df4727a09b083792f5e24de0</gtr:id><gtr:otherNames>Patel D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a843e8e0772b4.81126003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD8B796F-DA98-4843-96BD-2AB38A559011</gtr:id><gtr:title>TEFM (c17orf42) is necessary for transcription of human mtDNA.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d383d560f7c020e3b3e59a36dd85c29c"><gtr:id>d383d560f7c020e3b3e59a36dd85c29c</gtr:id><gtr:otherNames>Minczuk M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>54638194c20841.64994158</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06F6C9FF-1AD7-4421-86A7-EE5A11A4AF90</gtr:id><gtr:title>Engineered mtZFNs for Manipulation of Human Mitochondrial DNA Heteroplasmy.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7aec26dc8e9b89f9fd14eec6e079fea"><gtr:id>f7aec26dc8e9b89f9fd14eec6e079fea</gtr:id><gtr:otherNames>Gammage PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>56e14584ea1a19.25407811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F8E178A-AD67-4FFB-9867-89FA154218FA</gtr:id><gtr:title>C7orf30 is necessary for biogenesis of the large subunit of the mitochondrial ribosome.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32c739ac12bf8fb6b582f9ac7f6af3f3"><gtr:id>32c739ac12bf8fb6b582f9ac7f6af3f3</gtr:id><gtr:otherNames>Rorbach J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>54638195209562.35894999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70383A69-2300-4D88-A28F-0FBFFC6219D6</gtr:id><gtr:title>New insights into the phenotype of FARS2 deficiency.</gtr:title><gtr:parentPublicationTitle>Molecular genetics and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65752e278bc08dada2996d75f0481501"><gtr:id>65752e278bc08dada2996d75f0481501</gtr:id><gtr:otherNames>Vantroys E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1096-7192</gtr:issn><gtr:outcomeId>5a843eaa3133c1.31919006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBDDCF05-6311-4491-B6BF-4A747C6C5C88</gtr:id><gtr:title>MPV17L2 is required for ribosome assembly in mitochondria.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca3c3837edc29825f95fc70a324f122a"><gtr:id>ca3c3837edc29825f95fc70a324f122a</gtr:id><gtr:otherNames>Dalla Rosa I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>54638196b18ba5.11264312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>982D55B5-CF0A-40F6-9F84-1F64AF245ABF</gtr:id><gtr:title>Amino acid starvation has opposite effects on mitochondrial and cytosolic protein synthesis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/093f61b06630a3ad89eab7ae69c5b7f3"><gtr:id>093f61b06630a3ad89eab7ae69c5b7f3</gtr:id><gtr:otherNames>Johnson MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>546381966892e9.68580985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A408BDB-5B7B-4692-B776-62993B673F8C</gtr:id><gtr:title>Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95c5583b627c162ed22d4038ba7ebb73"><gtr:id>95c5583b627c162ed22d4038ba7ebb73</gtr:id><gtr:otherNames>Kopajtich R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>doi_55f985985ea0dac1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>521563B7-163A-47F2-AD42-6B497076A310</gtr:id><gtr:title>Mitochondria: mitochondrial RNA metabolism and human disease.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad20d2e153b1474420fbb737d220b7d2"><gtr:id>ad20d2e153b1474420fbb737d220b7d2</gtr:id><gtr:otherNames>Nicholls TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>54638195bc32e0.66890218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEF9B3A9-6BE6-47E7-9B25-1A58FB27B967</gtr:id><gtr:title>ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35d3a74312ac86d45efc47ac78a3c98c"><gtr:id>35d3a74312ac86d45efc47ac78a3c98c</gtr:id><gtr:otherNames>Haack TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>54638195e58e78.83872673</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21C3BD6A-20EF-46C1-A99C-6DE8C2DCA731</gtr:id><gtr:title>Heterozygous SSBP1 start loss mutation co-segregates with hearing loss and the m.1555A&amp;gt;G mtDNA variant in a large multigenerational family.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d406079946f3d96dfc81e3954f097e6"><gtr:id>5d406079946f3d96dfc81e3954f097e6</gtr:id><gtr:otherNames>Kullar PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5a843eeed103b4.78204170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E9AFB13-A81D-4356-A7A0-E71495C87182</gtr:id><gtr:title>An upstream open reading frame and the context of the two AUG codons affect the abundance of mitochondrial and nuclear RNase H1.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99fb597547943c01ed70225cefc2e694"><gtr:id>99fb597547943c01ed70225cefc2e694</gtr:id><gtr:otherNames>Suzuki Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>546381949dffc0.35408865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B170D6BA-F33B-46EA-9F42-BDA6E85BD09A</gtr:id><gtr:title>Human mitochondrial ribosomes can switch structural tRNAs - but when and why?</gtr:title><gtr:parentPublicationTitle>RNA biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8882b7e97e6f0b647ca454e1394d4920"><gtr:id>8882b7e97e6f0b647ca454e1394d4920</gtr:id><gtr:otherNames>Chrzanowska-Lightowlers Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1547-6286</gtr:issn><gtr:outcomeId>5a843e0f5f72d6.08986230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22213C99-8D3A-470E-8690-57BD2B6236B0</gtr:id><gtr:title>Linear mtDNA fragments and unusual mtDNA rearrangements associated with pathological deficiency of MGME1 exonuclease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad20d2e153b1474420fbb737d220b7d2"><gtr:id>ad20d2e153b1474420fbb737d220b7d2</gtr:id><gtr:otherNames>Nicholls TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>54638196d8e428.70173055</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03FE876D-B7D0-45B7-8D04-41D05C46B1BA</gtr:id><gtr:title>In D-loop: 40 years of mitochondrial 7S DNA.</gtr:title><gtr:parentPublicationTitle>Experimental gerontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad20d2e153b1474420fbb737d220b7d2"><gtr:id>ad20d2e153b1474420fbb737d220b7d2</gtr:id><gtr:otherNames>Nicholls TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0531-5565</gtr:issn><gtr:outcomeId>55b8d024421a00.94235345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C897421-7AFF-45E5-B7EE-68A36AA68CCD</gtr:id><gtr:title>Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7aec26dc8e9b89f9fd14eec6e079fea"><gtr:id>f7aec26dc8e9b89f9fd14eec6e079fea</gtr:id><gtr:otherNames>Gammage PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>5463819614d4f1.54081407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9642CA04-ECD2-4C9F-81EA-37E5578B4C50</gtr:id><gtr:title>Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3529a5847bdae5d649e5d1d7ba2af397"><gtr:id>3529a5847bdae5d649e5d1d7ba2af397</gtr:id><gtr:otherNames>Garone C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5a843e63418b43.00254485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9EB5E79-D076-4351-914B-9766CA860D8A</gtr:id><gtr:title>Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized.</gtr:title><gtr:parentPublicationTitle>Trends in genetics : TIG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7aec26dc8e9b89f9fd14eec6e079fea"><gtr:id>f7aec26dc8e9b89f9fd14eec6e079fea</gtr:id><gtr:otherNames>Gammage PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0168-9525</gtr:issn><gtr:outcomeId>5a843ed0450781.58290439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>987EBCB6-BEF5-4D4C-B949-001CBA9E6746</gtr:id><gtr:title>PDE12 removes mitochondrial RNA poly(A) tails and controls translation in human mitochondria.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32c739ac12bf8fb6b582f9ac7f6af3f3"><gtr:id>32c739ac12bf8fb6b582f9ac7f6af3f3</gtr:id><gtr:otherNames>Rorbach J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>54638194ef0930.80008214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBCA1B68-58AA-4D3A-BAFA-6BB68ED2EE21</gtr:id><gtr:title>Alternative translation initiation augments the human mitochondrial proteome.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4021e262ccd4c480fe5ffb8410648551"><gtr:id>4021e262ccd4c480fe5ffb8410648551</gtr:id><gtr:otherNames>Kazak L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5463819568a517.26169592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E443A5D3-114E-4F4A-9D97-E284187E5DA4</gtr:id><gtr:title>Mitochondrial transcript maturation and its disorders.</gtr:title><gtr:parentPublicationTitle>Journal of inherited metabolic disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccf0eedf7f0400f775fe1203610bd51b"><gtr:id>ccf0eedf7f0400f775fe1203610bd51b</gtr:id><gtr:otherNames>Van Haute L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0141-8955</gtr:issn><gtr:outcomeId>55b8d024e752c4.08550980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78EA332C-C8CB-4DBF-87A2-C8835D114E9E</gtr:id><gtr:title>Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7aec26dc8e9b89f9fd14eec6e079fea"><gtr:id>f7aec26dc8e9b89f9fd14eec6e079fea</gtr:id><gtr:otherNames>Gammage PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>58bea991a1a1f6.21335387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D783258-08D4-453C-BF89-B2878D4E82E4</gtr:id><gtr:title>Human Cytomegalovirus Infection Upregulates the Mitochondrial Transcription and Translation Machineries.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d724df103e65732990a9b3434a133c1d"><gtr:id>d724df103e65732990a9b3434a133c1d</gtr:id><gtr:otherNames>Karniely S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d515f0d7df2.70029774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49AF8927-2046-41C8-B246-41960670AD07</gtr:id><gtr:title>The post-transcriptional life of mammalian mitochondrial RNA.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32c739ac12bf8fb6b582f9ac7f6af3f3"><gtr:id>32c739ac12bf8fb6b582f9ac7f6af3f3</gtr:id><gtr:otherNames>Rorbach J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5463819544ed87.46608520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CED9CFFD-5DB8-492F-AECD-BA0792A0769D</gtr:id><gtr:title>Deficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccf0eedf7f0400f775fe1203610bd51b"><gtr:id>ccf0eedf7f0400f775fe1203610bd51b</gtr:id><gtr:otherNames>Van Haute L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d6b943387c2.74965189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BED0231D-A426-4891-815D-A2DFCF212B74</gtr:id><gtr:title>TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cddd2bef272a98bf3ef76e946616c4a"><gtr:id>5cddd2bef272a98bf3ef76e946616c4a</gtr:id><gtr:otherNames>Powell CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>55b8d025378273.69935219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57E65FF9-CCE5-43CE-95AE-2B505C3DCE61</gtr:id><gtr:title>Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e79164cb3f8ffcc54d30c3fbd52bda32"><gtr:id>e79164cb3f8ffcc54d30c3fbd52bda32</gtr:id><gtr:otherNames>Kornblum C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5463819594da74.36005082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3B30A4D-8410-4E92-B0B1-C4C4E8848CBF</gtr:id><gtr:title>Nuclear-encoded factors involved in post-transcriptional processing and modification of mitochondrial tRNAs in human disease.</gtr:title><gtr:parentPublicationTitle>Frontiers in genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cddd2bef272a98bf3ef76e946616c4a"><gtr:id>5cddd2bef272a98bf3ef76e946616c4a</gtr:id><gtr:otherNames>Powell CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-8021</gtr:issn><gtr:outcomeId>55b8d024878336.50386426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BFC3601-FB53-49F2-AE84-43DEA9D8F57D</gtr:id><gtr:title>Engineered zinc finger proteins for manipulation of the human mitochondrial genome.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d383d560f7c020e3b3e59a36dd85c29c"><gtr:id>d383d560f7c020e3b3e59a36dd85c29c</gtr:id><gtr:otherNames>Minczuk M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>546381947445d6.82727827</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105697135</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>